Trials / Completed
CompletedNCT01347879
A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris
PCTA206/11 A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi Center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 153 (actual)
- Sponsor
- Photocure · Industry
- Sex
- All
- Age
- 12 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to evaluate the efficacy and safety of Visonac Photodynamic Therapy (PDT) in patients with severe acne, score 4 on global IGA scale. The null hypothesis is that Visonac PDT is equal to vehicle PDT against the alternative hypothesis that Visonac PDT is different compared to vehicle PDT at week 12.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Visonac PDT | cream application prior to illumination with red light |
| DRUG | Vehicle cream with PDT | placebo/vehicle cream application prior to illumination with red light |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-04-01
- Completion
- 2012-05-01
- First posted
- 2011-05-04
- Last updated
- 2014-01-16
- Results posted
- 2014-01-16
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01347879. Inclusion in this directory is not an endorsement.